US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
All News
Headline News
Barchart.com
Benzinga
BreakingCrypto
Chartmill
Finterra
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
PredictStreet
StockStory
Stocktwits
Talk Markets
TokenRing AI
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
B2i Digital
Brandpoint
BusinesNews Wire
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
PulseBulletin.com
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
SP Tech Solutions
StatePoint
TheNewswire
Visibility
Worldnewswire
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >
Galimedix Therapeutics presents baseline data from Phase 2 eDREAM trial highlighting patient-tailored microperimetry as a sensitive and precise functional measurement in geographic atrophy studies
October 01, 2026
From
Galimedix Therapeutics, Inc.
Via
GlobeNewswire
FTI Consulting Appoints Christina Morris as a Senior Managing Director to Expand AI-Enabled Healthcare Capabilities
October 01, 2026
From
FTI Consulting, Inc.
Via
GlobeNewswire
Tickers
FCN
Helus Pharma Announces Completion of Legal Name Change
October 01, 2026
From
Helus Pharma
Via
GlobeNewswire
Tickers
HELP
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)
October 01, 2026
From
Artiva Biotherapeutics, Inc.
Via
GlobeNewswire
Tickers
ARTV
Streamex CEO Henry McPhie to Embark on Asia Tour with Events in Singapore and Hong Kong
October 01, 2026
From
Streamex Corp.
Via
GlobeNewswire
Tickers
STEX
Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD
October 01, 2026
From
Wave Life Sciences USA, Inc.
Via
GlobeNewswire
Tickers
WVE
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
October 01, 2026
From
InflaRx N.V.
Via
GlobeNewswire
Tickers
IFRX
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
October 01, 2026
From
Arbutus Biopharma Corporation
Via
GlobeNewswire
Tickers
ABUS
Habit Is Giving Away Alex Vesia Bobbleheads. Yes, He’s Holding His Double Play Char
October 01, 2026
From
Habit Burger & Grill
Via
GlobeNewswire
Edible Garden Purchases a 6.2 Acre Building in Webster City, Iowa to Develop 100+ Million Unit Ready-to-Drink Manufacturing Platform
October 01, 2026
From
Edible Garden AG Incorporated
Via
GlobeNewswire
Tickers
EDBL
EDBLW
Calian completes sale of U.S. commercial IT business to Trace3
October 01, 2026
From
Calian Group Ltd.
Via
GlobeNewswire
Tickers
TSX:CGY
OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course
October 01, 2026
From
OrthoPediatrics Corp.
Via
GlobeNewswire
Tickers
KIDS
Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development
October 01, 2026
From
Shattuck Labs, Inc.
Via
GlobeNewswire
Tickers
STTK
Amplify ETFs Highlights HACK and HAKY During Cybersecurity Awareness Month
October 01, 2026
From
Amplify ETFs
Via
GlobeNewswire
Origin Agritech Strengthens Liquidity by Selling Its Xinjiang Seed Subsidiary and Leasing Back the Production Base
October 01, 2026
From
Origin Agritech Ltd.
Via
GlobeNewswire
Tickers
SEED
Controlled Thermal Resources and Plum Acquisition Corp. IV Announce Strengthened Capital Structure to Advance Hell’s Kitchen Geothermal Power and Critical Minerals Project
October 01, 2026
From
Controlled Thermal Resources (US) Inc.
Via
GlobeNewswire
Tickers
PLMK
Fervo Energy Declares Commercial Operation at Cape Station Ahead of Schedule, Leading the Race for Next-Generation Geothermal Energy
October 01, 2026
From
Fervo Energy Company
Via
GlobeNewswire
Tickers
FRVO
PyroGenesis Confirms Completion of Installation of 4.5 MW Plasma Torch System at U.S. Defense and Aeronautics Research Facility
October 01, 2026
From
PyroGenesis Inc.
Via
GlobeNewswire
Tickers
PYRGF
TSX:PYR
Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
October 01, 2026
From
Fate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FATE
One of the most remote infrastructure projects in the US takes shape in Alaska
October 01, 2026
From
GHD Pty Ltd
Via
GlobeNewswire
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk
October 01, 2026
From
Monte Rosa Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GLUE
Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities
October 01, 2026
From
Foghorn Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FHTX
Templafy Report Finds 95% of Knowledge Workers Edit AI-Generated Documents Before They’re Business-Ready
October 01, 2026
From
Templafy Limited
Via
GlobeNewswire
Oceanic Iron Ore Corp. Begins Trading on OTCQX Best Market
October 01, 2026
From
OTC Markets
Via
GlobeNewswire
Tickers
FEOVF
OTCM
TSX-V:FEO.V
USA Rare Earth Completes CEO Transition
October 01, 2026
From
USA Rare Earth, Inc.
Via
GlobeNewswire
Tickers
USAR
USARW
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
October 01, 2026
From
Generate Biomedicines, Inc.
Via
GlobeNewswire
Tickers
GENB
Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
October 01, 2026
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Tickers
IOVA
Homes for Heroes Names Amit Kulkarni CEO
October 01, 2026
From
Homes for Heroes
Via
GlobeNewswire
Manifests Ireland Grows Customs Operations from 20,000 to 2 Million Annual Declarations with Descartes Customs Compliance Solution
October 01, 2026
From
The Descartes Systems Group Inc
Via
GlobeNewswire
Tickers
DSGX
TSX:DSG
National Fuel Gas Company Completes Acquisition of CenterPoint Energy's Ohio Natural Gas Utility
October 01, 2026
From
National Fuel Gas Company
Via
GlobeNewswire
Tickers
NFG
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
99
100
Next >